From the *Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark; and †Division of Nuclear Medicine, University of Pennsylvania Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Clin Nucl Med. 2014 Aug;39(8):701-3. doi: 10.1097/RLU.0000000000000487.
In 1976, 2 major molecular imaging events coincidentally took place: Clinical Nuclear Medicine was first published in June, and in August researchers at the Hospital of the University of Pennsylvania created the first images in humans with F-FDG. FDG was initially developed as part of an evolution set in motion by fundamental research studies with positron-emitting tracers in the 1950s by Michel Ter-Pegossian and coworkers at the Washington University. Today, Clinical Nuclear Medicine is a valued scientific contributor to the molecular imaging community, and FDG PET is considered the backbone of this evolving and exciting discipline.
1976 年,有 2 个重大的分子影像学事件同时发生:《临床核医学》于 6 月首次出版,同年 8 月,宾夕法尼亚大学医院的研究人员使用 F-FDG 首次在人体上获得图像。FDG 的最初开发是由 20 世纪 50 年代 Michel Ter-Pegossian 及其在华盛顿大学的同事们使用正电子发射示踪剂进行的基础研究引发的一系列演变的一部分。如今,《临床核医学》是分子影像学领域的重要科学贡献者,而 FDG PET 被认为是这一不断发展和令人兴奋的学科的基础。